Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CXCL1 is a small peptide belonging to the CXC chemokine family that primarily functions as a chemoattractant for neutrophils and other immune cells. It plays a key role in mediating leukocyte recruitment and activation to promote inflammation, wound healing, angiogenesis, and tumorigenesis. Elevated levels of CXCL1 have been observed in various pathological conditions, including chronic inflammation, fibrosis, cancer progression, and ischemia-reperfusion injury.
CXCL1 binds to CXCR2, a G protein-coupled receptor, activating intracellular signaling pathways including PI3Kγ/Akt, MAP kinases (ERK1/2), and PLCβ pathways, leading to further production of inflammatory cytokines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine ligand 1 (CXCL1).